In vivo enzymatic modulation of IgG antibodies prevents immune complex-dependent skin injury

Experimental Dermatology

Volumn 26, Issue 8, 2017, Pages 691-696

  Mihai, Sidonia ^a,b   Albert, Heike ^a   Ludwig, Ralf J ^c   Iwata, Hiroaki ^c,e   Björck, Lars ^d   Collin, Mattias ^d   Nimmerjahn, Falk ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c UNIVERSITY OF LÜBECK   (Germany)

^d LUND UNIVERSITY   (Sweden)

^e HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

EndoS; IdeS; immunoglobulin G; immunotherapy

Indexed keywords

COLLAGEN TYPE 7; ENDOGLYCOSIDASE S; FC RECEPTOR; GLYCOSIDASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G DEGRADING ENZYME; IMMUNOGLOBULIN HEAVY CHAIN; RECOMBINANT ENDOGLYCOSIDASE S; RECOMBINANT ENZYME; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; MAC-1-LIKE PROTEIN, STREPTOCOCCUS; NDOS PROTEIN, STREPTOCOCCUS PYOGENES;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHUS PHENOMENON; ARTICLE; BLISTER; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; EFFECTOR CELL; EPIDERMOLYSIS BULLOSA ACQUISITA; EXTRAVASCULAR SPACE; FEMALE; HINGE REGION; IMMUNE COMPLEX DISEASE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN PURIFICATION; SKIN BIOPSY; SKIN INJURY; STREPTOCOCCUS PYOGENES; ANIMAL; C57BL MOUSE; IMMUNOLOGY; METABOLISM; PRECLINICAL STUDY;

ANIMALS; ARTHUS REACTION; BACTERIAL PROTEINS; COLLAGEN TYPE VII; DRUG EVALUATION, PRECLINICAL; EPIDERMOLYSIS BULLOSA ACQUISITA; FEMALE; GLYCOSIDE HYDROLASES; IMMUNOGLOBULIN G; MICE, INBRED C57BL;

EID: 85007202913     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.13163     Document Type: Article

References (28)

1. Schwab I, Nimmerjahn F. Nat Rev Immunol. 2013;13:176–189.
2. Schmidt RE, Gessner JE. Immunol Lett. 2005;100:56–67.
3. Allhorn M, Olin AI, Nimmerjahn F, Collin M. PLoS One. 2008;3:e1413.
4. Albert H, Collin M, Dudziak D, Ravetch JV, Nimmerjahn F. Proc Natl Acad Sci USA. 2008;105:15005–15009.
5. Collin M, Ehlers M. Exp Dermatol. 2013;22:511–514.
6. Joly P, Roujeau JC, Benichou J, et al. N Engl J Med. 2002;346:321–327.
7. von Pawel-Rammingen U, Johansson BP, Björck L. EMBO J. 2002;21:1607–1615.
8. Collin M, Olsén A. EMBO J. 2001;20:3046–3055.
9. Collin M, Shannon O, Björck L. Proc Natl Acad Sci USA. 2008;105:4265–4270.
10. Collin M, Olsén A. Infect Immun. 2001;69:7187–7189.
11. Nandakumar KS, Johansson BP, Björck Land Holmdahl R. Arthritis Rheum. 2007;56:3253–3260.
12. Yang R, Otten MA, Hellmark T, et al. Nephrol Dial Transplant. 2010;25:2479–2486.
13. Ludwig RJ, Kalies K, Kohl J, Zillikens D, Schmidt E. Trends Mol Med. 2013;19:501–512.
14. Ludwig R J. ISRN Dermatol. 2013;2013:812029.
15. Takai T. Nat Rev Immunol. 2002;2:580–592.
16. Hazenbos WL, Gessner JE, Hofhuis FM, et al. Immunity. 1996;5:181–188.
17. Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV. Cell. 1994;76:519–529.
18. Sylvestre DL, Ravetch JV. Science. 1994;265:1095–1098.
19. Sitaru C, Mihai S, Otto C, et al. J Clin Invest. 2005;115:870–878.
20. Chiriac MT, Roesler J, Sindrilaru A, Scharffetter-Kochanek K, Zillikens D, Sitaru C. J Pathol. 2007;212:56–65.
21. Mihai S, Chiriac MT, Takahashi K, et al. J Immunol. 2007;178:6514–6521.
22. Fries LF, Gaither TA, Hammer CH, Frank MM. J Exp Med. 1984;160:1640–1655.
23. Johansson BP, Shannon O, Björck L. PLoS One. 2008;3:e1692.
24. Tradtrantip L, Asavapanumas N, Verkman AS. Mol Pharmacol. 2013;83:1268–1275.
25. Hirose M, Vafia K, Kalies K, et al. J Autoimmun. 2012;39:304–314.
26. Banda NK, Wood AK, Takahashi K, et al. Arthritis Rheum. 2008;58:3081–3089.
27. Nandakumar KS, Collin M, Olsen A, et al. Eur J Immunol. 2007;37:2973–2982.
28. Åkesson P, Rasmussen M, Mascini E, et al. J Infect Dis. 2004;189:797–804.